Resistant hypertension
This algorithm describes the ongoing resistant hypertension algorithm used in eMERGE, which was a network phenotype within the eMERGE-I and eMERGE-II sites.
Owner Phenotyping Groups:
View Phenotyping Groups:
Final
Vanderbilt University
Rheumatoid Arthritis - Demonstration Project
Rheumatoid Arthritis phenotype algorithm for the DNA Databank demonstration project.
|
|
Record Count |
Diagnostic Codes? |
Text Keywords? |
Narrative Notes to search |
Other rules |
|
Cases |
Owner Phenotyping Groups:
View Phenotyping Groups:
Final
Statins and MACE
Phenotype Description: Patients on statins for primary prevention who develop an AMI or 1st AMI.
Below are algorithms used to identify AMI and 1st AMI cohort at BioVU. If you have questions regarding any of the information presented on this page, you may contact either:
Wei-Qi Wei at wei-qi.wei@vanderbilt.edu
Joshua Denny at josh.denny@vanderbilt.edu
Owner Phenotyping Groups:
View Phenotyping Groups:
Final
Type 2 Diabetes - Demonstration Project
Type 2 Diabetes phenotype algorithm for the DNA Databank Demonstration Project.
Owner Phenotyping Groups:
View Phenotyping Groups:
Final
Warfarin dose/response
This algorithm identifies patients who have a stable within-range INR (assuming a target INR of 2-3) over at least a three week period and correlates with their warfarin weekly dose. It is used to identify pharmacogenetics behind warfarin stable dose.
Owner Phenotyping Groups:
View Phenotyping Groups:
Final